StockNews.com started coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a research note published on Saturday. The firm issued a hold rating on the biotechnology company’s stock.
Bellerophon Therapeutics Stock Performance
Shares of BLPH stock opened at $0.05 on Friday. The stock has a 50 day simple moving average of $0.06 and a 200-day simple moving average of $0.06. The company has a market cap of $623,730.00, a price-to-earnings ratio of -0.06 and a beta of 0.73. Bellerophon Therapeutics has a 12-month low of $0.03 and a 12-month high of $0.52.
About Bellerophon Therapeutics
Further Reading
- Five stocks we like better than Bellerophon Therapeutics
- How to Calculate Options Profits
- Survey: Top 175 Fittest Retirement Locations in America
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Kimberly-Clark Stock Dips and a Buying Opportunity Emerges
- Stock Splits, Do They Really Impact Investors?
- Leading Gold Stock Shines With Q2 2024 Earnings Release
Receive News & Ratings for Bellerophon Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bellerophon Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.